Posted by AGORACOM-JC
at 7:12 PM on Friday, April 30th, 2021
When it comes to small-cap companies, tech-focused Datametrex AI is in rarefied air; they have not one but two successful independent divisions each capable of being a company maker: COVID-19 test kit distribution, and AI-driven social media monitoring and discovery.
Financial Highlights for year ending December 31, 2020:
Revenue of $12.3M vs. $3.4M for FY 2019
An increase of 264%
We sat down with CEO Marshall Gunter to discuss these highlights, the COVID-19 landscape, telemedicine, 2021 plans, and more.
Posted by AGORACOM-JC
at 5:22 PM on Thursday, April 29th, 2021
Valeo Pharma is already a successful, revenue generating, small cap Canadian pharmaceutical company that acquires the Canadian rights to commercialized drugs in other parts of the world that don’t have Canada on their radar as a target market.
This “in-license” business model is ingenious because it means ZERO developmental or clinical risk, which is the downfall of most small cap pharma companies.
This model has resulted in the following success:
2020 net revenues of $7.5 million
2021 is expected to double to $15 million
Commercializing Novartis Asthma Therapies In Canada
Closed $6.6 Million Financing With Insiders Taking ~ 40%
If that was all Valeo had, most investors would be happy to sit back and watch the Company grow.
But then came Redesca. We are going to save you the science and tell you that Redesca belongs to a class of anticoagulant medications (blood thinners) called LMWH. The size of the Canadian LMWH market is over $200M per year and Valeo believes they can capture 15-20% of this market. If you’re doing back of napkin math, that equates to $30,000,000 – $40,000,000 per year in revenues.
But how does a new product capture that much market share? Glad you asked because we asked CEO Steve Saviuk the same question. Competition is tough in all markets and they don’t let someone take 15-20% market share without one hell of a fight. Saviuk agreed and gave the following 3 reasons:
1. Redesca has an 8-year international track record of safety and efficacy. It is already well known
2. Redesca is flat out cheaper, which is music to the ears of Provincial Health Ministries whose budgets have been stretched to the max this year no thanks to COVID-19.
Vaelo is so confident that it stated “This is great news for the Canadian healthcare system …. and is expected to help provide significant savings to provincial healthcare systems.”
More than just lip service, $VPH just announced that Redesca is now listed on the Ontario Public Drug Program, which means the government will cover its costs for all public use. Moreover, $VPH expects additional Provinces to follow.
If you love revenue generating, growing and blue sky potential small cap companies, then this Valeo interview is a must watch.
Posted by AGORACOM-JC
at 4:20 PM on Wednesday, April 28th, 2021
The paradigm shifting, parabolic growth of plant based foods and a plant based life is unstoppable, with the plant-based food market alone expected to reach $74.2 billion by 2027.
With a line up of plant based products and services that includes:
Plant Based Meal Delivery
Plant Based Snack Products
Plant Based Pet foods
Plant Based Restaurant Locator
Plant Based Recipes
Plant Based Essentials …. Like Chocolate (Essential? You Bet)
And …… Plant Based …. PLANTS (It’s A BIG Business!)
If you believe in the massive paradigm shift towards plant based foods and more, be sure to watch and share this great interview with PlantX CEO Julia Frank.
Posted by AGORACOM-JC
at 6:40 PM on Monday, April 26th, 2021
When the Facebook data privacy scandal broke out, the world woke up to just how badly our individual data was being traded, used and most importantly, the amount of profit being generated by major corporations at our expense.
This led to the enactment of the biggest data privacy laws in history. Specifically, General Data Protection Regulation (GDPR) out of Europe and the California Consumer Privacy Act (CCPA).
Enter LQID (formerly KABN). The Company Turns The Problem Of Data Privacy Into A Profit For Individuals, While Providing Big Businesses With New & Compliant Business Models.
More than just lip service, $LQID has made some major announcements, including joining the Trust Over IP Foundation, which includes over 170 members including IBM, Mastercard, Accenture and many other global leaders who are defining a complete architecture for Internet-scale digital trust.
Does that sound like a mouthful? Yeah, it does. But all you have to really understand for now is that digital ID, privacy and monetization is going to become a reality in the very near future. Government regulations are enforcing it. Consumers are demanding it and $LQID is delivering it at such an advanced scale that the Trust Over IP Foundation provided them with a strategic role as a Steering Member.
If that wasn’t enough proof for you, Google validated the $LQID business model with this stunning announcement at the beginning of March:
Google believes these types of tracking methods don’t “meet rising consumer expectations for privacy, nor will they stand up to rapidly evolving regulatory restrictions, and therefore aren’t a sustainable long term investment.”
Google is experimenting with tools in its Privacy Sandbox that are designed to allow advertising to continue to work on the web but in a less privacy-encroaching way.
“Keeping the internet open and accessible for everyone requires all of us to do more to protect privacy — and that means an end to not only third-party cookies, but also any technology used for tracking individual people as they browse the web,” David Temkin, Google’s director of product management for ads privacy and trust,
What is the potential outcome of this major shift by Google?
“Google’s decision could upend the ad industry, which has relied on these types of tracking tools”
Now the data privacy and monetization game is underway with LQID sitting in a great position within the industry and the dominant position within the small cap world. That dominant position got even stronger today when $LQID announced the Launch Of KABN Prepaid Visa Card and Mobile Card App in Canada
WHY IS THIS SO IMPORTANT?
If consumers are going to switch to Liquid Avatar to protect and monetize their identity, they are also going to need ways to pay for the great individualized offers presented to them, which means $LQID has just added another super valuable piece of the puzzle to its solution
Watch this interview with CEO David Lucatch for an even deeper discussion into what this all means for $LQID and YOU.
Our CEO and CMO spoke with Streetwise Reports about how Cedar Clinical Research is positioned to develop a new option for treatment-resistant depression.
On April 19, 1943, chemist Albert Hofmann took .00005 teaspoons of LSD. As he rode his bicycle home, he realized that the world had just changed. By Novamind CMO, Dr. Reid Robison and Kirsten Hirst.
More Americans died from drug overdoses in 2020 than ever before. As psychedelic-assisted treatment options approach mainstream medicine, Time looks at ibogaine as a way to treat addiction like few treatments can.
Psilocybin works. Researchers in London released findings from a phase 2 trial indicating that a couple of doses of psilocybin may treat depression as well as one of the most commonly prescribed antidepressants. More research is required but leaders of the study were surprised with the outcome.
Posted by AGORACOM-JC
at 6:01 PM on Friday, April 23rd, 2021
PK Beans is a revenue generating children’s wellness brand that is differentiating itself and super charging growth through great innovation and technology integration.
This is proven by the following:
Canada’s Only Public Company With Predominantly Female Board of Directors
Posted by AGORACOM-JC
at 4:42 PM on Friday, April 23rd, 2021
HPQ Silicon Resources $HPQ $HPQFF is a Quebec-based company that is developing a portfolio of high value-added silicon products sought after by battery and electric vehicle manufacturers.
If that sounds a lot like what other small companies are saying lately, $HPQ differentiates itself as a leader of the pack thanks to the following:
To discuss the importance and the implications of this milestone, this excerpt from the press release says it all:
“Once the final equipment modifications are completed, the goal of the program will be to produce qualified samples which will then be tested by a third-party, the Institut National de Recherche Scientifique (INRS), and subsequently to awaiting battery manufacturers and automobile manufacturers.”
Peter Pascali, President and CEO of PyroGenesis added a little more excitement when he stated
“It is even more exciting when one considers the impact this could have on addressing the challenges facing the EV battery space.”
Watch this great interview with $HPQ CEO Bernard Tourillon to get the full picture on next steps!
